The clinical heterogeneity of genetic diseases characterized by well identified mutations is a striking feature. The diseases related to COL4A1 mutations are a new example of this statement. The COL4A1 gene codes for the α1 chain of type IV collagen (α1(IV)), a major ubiquitous component of basement membranes. Mutations in this gene were first reported by neurologists in families with autosomal dominant forms of porencephaly. The porencephalic cavity is caused by cerebral hemorrhage that occurred during the intrauterine or neonatal period. A broad range of neurologic features have been reported, including infantile hemiplegia, mental retardation, and hemorrhagic strokes in children or in adults that are triggered by trauma or anticoagulation. In another group of patients, cerebral small vessel disease (CSVD) predominates, with leukoencephalopathy, lacunar infarcts, and micro- or macrobleeds without porencephaly. Various eye abnormalities may be found, including retinal arteriolar tortuosity, cataract, or anterior segment dysgenesis of the eye (Axenfeld–Rieger anomaly). This CSVD is reminiscent of the cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) because of mutations in the NOTCH 3 receptor. Rare cases of CADASIL syndrome associated with renal involvement have been reported. Electron microscopic analysis showed pathognomonic granular osmiophilic material in cerebral, cutaneous, and intrarenal arteries. Immunohistochemistry using an antibody specific for the NOTCH 3 ectodomain showed positive granular staining in the same vessels, whereas no staining was found in a patient with common nephroangiosclerosis (1). In addition, hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) was reported in 1997 and is caused by mutations in the TREX1 transcription factor (2). This represents a distinctive subtype of retinal vasculopathy with cerebral leukodystrophy. The third mode of presentation of COL4A1 mutations has been described by Plaisier et al., and the patients first presented with renal disease (3). This autosomal dominant entity has been named HANAC syndrome, or hereditary angiopathy with nephropathy, aneurysm, and muscle cramps (3). Mutations affect glycine residues in close proximity in exons 24 and 25 within the triple-helix domain of the protein. The main phenotypic features encompass a nephropathy with hematuria or bilateral renal cysts, a muscular disease with cramps, and retinal arterial tortuosity. Skin and kidney biopsies show by electron microscopy abnormal thickening, multilamination, and/or focal disruption of the basement membranes. In their recent study, Alamovitch et al. collected data on the neurologic condition of 14 HANAC patients (ranging from 22 to 57 years of age) belonging to three unrelated families. Nine were interviewed and examined. For the four deceased subjects (ages at death ranging from 60 to 69 years), the causes of death were not neurologic. One patient declined to participate in this study. No patient had infantile hemiparesia, mental retardation, history of stroke, or spontaneous subarachnoid or intracerebral hemorrhage. Only two patients had a history of cerebrovascular injury: acute cerebellar ataxia in one and posttraumatic cerebromeningeal hemorrhage in the other. In nine patients, brain magnetic resonance imaging (MRI) was performed and all showed at least one abnormality. No porencephaly was observed. Multiple intracranial aneurysms (ICAs) were found in three patients; these ICAs were small, asymptomatic, and localized on the intracranial carotid at the level of the carotid siphon. Seven patients had MRI abnormalities consistent with CSVD dominated by leukoencephalopathy. No cortical involvement was detected. HANAC syndrome therefore constitutes a new monogenic cause of familial ICAs. Of interest, two other inherited diseases with syndromic ICAs have been identified: autosomal dominant polycystic kidney disease and Ehlers–Danlos syndrome type IV with mutations in COL3A1. Regarding diagnosis, skin vessels changes have been described in three autosomal dominant angiopathies: CADASIL, HERNS, and HANAC. Skin biopsy analysis may provide a cost-effective guide before practicing an expensive and time-consuming gene screening. These entities such as HANAC or CADASIL syndromes can be considered as “systemic basalopathies.” They also reopened the field of renal angiopathies/nephrosclerosis/nephroangiosclerosis by using new tools of investigation and by suggesting more pathophysiological heterogeneity than previously thought.